Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroto Matsui

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy]Kensuke Yamada, Kazuhiko Sakamoto, Takao Tamesa, et al.
Breast Cancer (Tokyo, Japan)|April 26, 2017
A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancerShigeru Yamamoto, Noriko Maeda, Yukiko Nagashima, et al.
Pancreas|April 9, 2021
Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune SurveillanceYasuhiro Fujiwara, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2020
A high number of PD-L1<sup>+</sup> CD14<sup>+</sup> monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitorsKiyohiro Ando, Kazuyuki Hamada, Midori Shida, et al.
Pancreas|March 26, 2024
Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001)Hiroto Matsui, Tatsuya Ioka, Tsuyoshi Takahashi, et al.
Oncology Letters|October 23, 2018
Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer-B hepatocellular carcinomaSatoshi Matsukuma, Kazuhiko Sakamoto, Yoshihiro Tokuhisa, et al.
BMC Cancer|March 12, 2022
Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cellsRyouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, et al.
Medicine|January 14, 2022
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case reportKazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, et al.
BMC Cancer|February 2, 2024
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancerKei Furuya, Masao Nakajima, Ryouichi Tsunedomi, et al.
Annals of Gastroenterological Surgery|December 15, 2020
Viral elimination is essential for improving surgical outcomes of hepatitis C virus-related hepatocellular carcinoma: Multicenter retrospective analysisMasao Nakajima, Shogo Kobayashi, Hiroshi Wada, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy]Kensuke Yamada, Kazuhiko Sakamoto, Takao Tamesa, et al.
Breast Cancer (Tokyo, Japan)|April 26, 2017
A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancerShigeru Yamamoto, Noriko Maeda, Yukiko Nagashima, et al.
Pancreas|April 9, 2021
Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune SurveillanceYasuhiro Fujiwara, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2020
A high number of PD-L1<sup>+</sup> CD14<sup>+</sup> monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitorsKiyohiro Ando, Kazuyuki Hamada, Midori Shida, et al.
Pancreas|March 26, 2024
Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001)Hiroto Matsui, Tatsuya Ioka, Tsuyoshi Takahashi, et al.
Oncology Letters|October 23, 2018
Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer-B hepatocellular carcinomaSatoshi Matsukuma, Kazuhiko Sakamoto, Yoshihiro Tokuhisa, et al.
BMC Cancer|March 12, 2022
Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cellsRyouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, et al.
Medicine|January 14, 2022
A case of bronchial asthma as an immune-related adverse event of pembrolizumab treatment for bladder cancer: A case reportKazuyuki Hamada, Kiyoshi Yoshimura, Kazuhiko Oshinomi, et al.
BMC Cancer|February 2, 2024
High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancerKei Furuya, Masao Nakajima, Ryouichi Tsunedomi, et al.
Annals of Gastroenterological Surgery|December 15, 2020
Viral elimination is essential for improving surgical outcomes of hepatitis C virus-related hepatocellular carcinoma: Multicenter retrospective analysisMasao Nakajima, Shogo Kobayashi, Hiroshi Wada, et al.
Pageof 12